<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Research - Sharma Lab</title>
  <link rel="stylesheet" href="styles.css" />
</head>
<body>
  <header>
    <h1>Ajay Kumar Sharma Lab</h1>
    <nav>
      <ul>
        <li><a href="index.html">Home</a></li>
        <li><a href="research.html">Research</a></li>
        <li><a href="team.html">Team</a></li>
        <li><a href="publications.html">Publications</a></li>
        <li><a href="news.html">News</a></li>
        <li><a href="gallery.html">Gallery</a></li>
        <li><a href="contact.html">Contact</a></li>
      </ul>
    </nav>
  </header>

  <main>
    <section>
      <h2>Our Research Focus</h2>
      <p>Our lab specializes in developing PET imaging agents and radiotherapeutics targeting highly expressed cancer receptors, particularly in ovarian and pancreatic cancers. We employ interdisciplinary approaches involving chemical synthesis, radiolabeling, cell-based assays, and small animal imaging.</p>

      <h3>Key Research Areas:</h3>
      <ul>
        <li>Development of F-18 labeled peptide derivatives for PD-L1 imaging</li>
        <li>CD38-targeted PET agents for multiple myeloma</li>
        <li>Theranostic agents for EphA2 targeting in pancreatic cancer</li>
        <li>In vivo stable fluorosulfate groups for late-stage F-18 labeling</li>
        <li>Molecular radiotherapy approaches for ovarian cancer treatment</li>
      </ul>

      <h3>Techniques We Use:</h3>
      <p>
        Radiochemistry (F-18, Cu-64, Lu-177), HPLC, LC-MS, NMR, MALDI-TOF, PET/CT imaging,
        biodistribution studies, in vitro assays, and in vivo animal models.
      </p>
    </section>
  </main>

  <footer>
    <p>&copy; 2025 Ajay Kumar Sharma Lab, Johns Hopkins University</p>
  </footer>
</body>
</html>
